Chapter 130 : Introduction

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Introduction, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap130-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap130-2.gif


This is the introductory chapter to the section . Proven and investigational tumor markers are mostly proteins that have proven or anticipated use in the diagnosis and management of cancer patients and patients receiving immunologic therapies. Diagnostic oncology and immunology laboratories all over the world currently measure a number of biomolecules released from tissue into body fluids that are markers of tumor presence and growth. The measurement of these analytes assists oncologists in making more accurate diagnoses and managing their patients with cancer, especially as it relates to monitoring therapy, detecting cancer recurrence, and assessing the patient’s prognosis. This has been a challenging area of diagnostic immunology because most tumor markers are not elevated under all cancerous conditions and others are elevated under non-cancer conditions such as benign or nonmalignant disease.

Citation: Detrick B, Hamilton R, Folds J. 2006. Introduction, p 1143-1144. In Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch130
Highlighted Text: Show | Hide
Loading full text...

Full text loading...



This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error